Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity

  • Galán Arriola, Carlos
  • Villena Gutiérrez, Rocío
  • Higuero Verdejo, María Isabel
  • Díaz Rengifo, Iván Alejandro
  • Pizarro Sánchez, Gonzalo
  • López Martín, Gonzalo J.
  • Molina Iracheta, Antonio de
  • Pérez Martínez, Claudia
  • García, Rodrigo D.
  • González Calle, David
  • Lobo González, Manuel
  • Sánchez Fernández, Pedro Luis
  • Oliver, Eduardo
  • Córdoba, Raúl
  • Fuster, Valentín
  • Sánchez González, Javier
  • Ibáñez, Borja
política de autoarchivo de la editorial https://academic.oup.com/pages/open-research/open-access/charges-licences-and-self-archiving/author-self-archiving-policy, [EN] AIMS: Anthracycline-induced cardiotoxicity (AIC) is a serious adverse effect among cancer patients. A central mechanism of AIC is irreversible mitochondrial damage. Despite major efforts, there are currently no effective therapies able to prevent AIC. METHODS AND RESULTS: Forty Large-White pigs were included. In Study 1, 20 pigs were randomized 1:1 to remote ischaemic preconditioning (RIPC, 3 cycles of 5 min leg ischaemia followed by 5 min reperfusion) or no pretreatment. RIPC was performed immediately before each intracoronary doxorubicin injections (0.45 mg/kg) given at Weeks 0, 2, 4, 6, and 8. A group of 10 pigs with no exposure to doxorubicin served as healthy controls. Pigs underwent serial cardiac magnetic resonance (CMR) exams at baseline and at Weeks 6, 8, 12, and 16, being sacrifice after that. In Study 2, 10 new pigs received 3 doxorubicin injections (with/out preceding RIPC) and were sacrificed at week 6. In Study 1, left ventricular ejection fraction (LVEF) depression was blunted animals receiving RIPC before doxorubicin (RIPC-Doxo), which had a significantly higher LVEF at Week 16 than doxorubicin treated pigs that received no pretreatment (Untreated-Doxo) (41.5 ± 9.1% vs. 32.5 ± 8.7%, P = 0.04). It was mainly due to conserved regional contractile function. In Study 2, transmission electron microscopy (TEM) at Week 6 showed fragmented mitochondria with severe morphological abnormalities in Untreated-Doxo pigs, together with upregulation of fission and autophagy proteins. At the end of the 16-week Study 1 protocol, TEM revealed overt mitochondrial fragmentation with structural fragmentation in Untreated-Doxo pigs, whereas interstitial fibrosis was less severe in RIPC+Doxo pigs. CONCLUSION: In a translatable large-animal model of AIC, RIPC applied immediately before each doxorubicin injection resulted in preserved cardiac contractility with significantly higher long-term LVEF and less cardiac fibrosis. RIPC prevented mitochondrial fragmentation and dysregulated autophagy from AIC early stages. RIPC is a promising intervention for testing in clinical trials in AIC, SI, This study is part of a project that has received funding from the European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Programme (ERC-Consolidator Grant agreement No. 819775 to B.I). The study was also partially funded by an ERA-CVD Joint Translational Call 2016 [funded through the Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (ERDF), # AC16/00021] and by a Health Research Project from the ISCIII-FIS (# PI16/02110). Carlos Gala´n-Arriola and Rocı´o VillenaGutie´rrez are P-FIS fellows (Instituto de Salud Carlos III). This study forms part of a research agreement between the CNIC and Philips Healthcare. The CNIC is supported by the ISCIII, the Ministerio de Ciencia e Innovacio´n, and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MEIC award SEV-2015-0505)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transcriptional reprogramming triggered by neonatal UV radiation or Lkb1 loss prevents BRAF V600E -induced growth arrest in melanocytes

  • McGrail, Kimberley|||0000-0001-7227-7306
  • Granado-Martínez, Paula|||0000-0002-7765-8914
  • Orsenigo, Roberto
  • Caratù, Ginevra|||0000-0003-1085-8062
  • Nieto, Paula
  • Heyn, Holger|||0000-0002-3276-1889
  • Ferrer, Berta|||0000-0002-1255-4647
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Muñoz Couselo, Eva|||0000-0001-7556-7608
  • García-Patos Briones, Vicente|||0000-0003-1654-6035
  • Recio Conde, Juan Ángel|||0000-0002-7320-3832
The mechanisms behind UVB-initiated, neonatal-specific melanoma linked to BRAF V600E are not well understood, particularly regarding its role in growth arrest. We found that, beyond mutations, neonatal UV irradiation or Lkb1 loss promotes a cell-autonomous transcriptional reprogramming that prevents BRAF V600E -induced growth arrest, leading to melanoma development. Using UVB-dependent and independent mouse models, genomic analyses, clinical data, and single-cell transcriptomics, we identified a transcriptional program that bypasses growth arrest, promoting melanoma. In humans, many of these genes are linked to poor survival and are upregulated in melanoma progression and other RAS pathway-driven tumors. Reconstitution experiments showed these genes cooperate with BRAF V600E in melanocyte transformation, dedifferentiation, and drug resistance. Depleting gene products like UPP1 highlights their potential as therapeutic targets. Our findings reveal that BRAF V600E -mutated melanomas can develop independently of nevus progression and identify novel targets for treatment.
Repisalud
Publicación Artículo científico (JournalArticle)

Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation.

  • Clemente-Moragón, Agustín
  • Gomez, Monica
  • Villena-Gutierrez, Rocio
  • Lalama, Doménica V
  • Garcia-Prieto, Jaime
  • Martinez, Fernando
  • Sanchez-Cabo, Fatima
  • Fuster, Valentin
  • Oliver, Eduardo
  • Ibáñez, Borja
Clinical guidelines recommend early intravenous β-blockers during ongoing myocardial infarction; however, it is unknown whether all β-blockers exert a similar cardioprotective effect. We experimentally compared three clinically approved intravenous β-blockers. Mice undergoing 45 min/24 h ischaemia-reperfusion (I/R) received vehicle, metoprolol, atenolol, or propranolol at min 35. The effect on neutrophil infiltration was tested in three models of exacerbated inflammation. Neutrophil migration was evaluated in vitro and in vivo by intravital microscopy. The effect of β-blockers on the conformation of the β1 adrenergic receptor was studied in silico. Of the tested β-blockers, only metoprolol ameliorated I/R injury [infarct size (IS) = 18.0% ± 0.03% for metoprolol vs. 35.9% ± 0.03% for vehicle; P < 0.01]. Atenolol and propranolol had no effect on IS. In the three exacerbated inflammation models, neutrophil infiltration was significantly attenuated only in the presence of metoprolol (60%, 50%, and 70% reductions vs. vehicle in myocardial I/R injury, thioglycolate-induced peritonitis, and lipopolysaccharide-induced acute lung injury, respectively). Migration studies confirmed the particular ability of metoprolol to disrupt neutrophil dynamics. In silico analysis indicated different intracellular β1 adrenergic receptor conformational changes when bound to metoprolol than to the other two β-blockers. Metoprolol exerts a disruptive action on neutrophil dynamics during exacerbated inflammation, resulting in an infarct-limiting effect not observed with atenolol or propranolol. The differential effect of β-blockers may be related to distinct conformational changes in the β1 adrenergic receptor upon metoprolol binding. If these data are confirmed in a clinical trial, metoprolol should become the intravenous β-blocker of choice for patients with ongoing infarction.
Repisalud
Publicación Artículo científico (JournalArticle)

Coronary microcirculation damage in anthracycline cardiotoxicity.

  • Galan-Arriola, Carlos
  • Vilchez-Tschischke, Jean Paul
  • Lobo, Manuel
  • Lopez, Gonzalo Javier
  • Molina-Iracheta, Antonio
  • Pérez-Martínez, Claudia
  • Villena-Gutierrez, Rocio
  • Macias, Alvaro
  • Díaz-Rengifo, Iván A
  • Oliver, Eduardo
  • Fuster, Valentin
  • Sanchez-Gonzalez, Javier
  • Ibáñez, Borja
The aim of this study was to study changes in coronary microcirculation status during and after several cycles of anthracycline treatment. Large-White male pigs (n = 40) were included in different experimental protocols (ExPr.) according to anthracycline cumulative exposure (0.45 mg/kg intracoronary (IC) doxorubicin per injection) and follow-up: Control (no doxorubicin); Single injection and sacrifice either at 48 hours (ExPr. 1) or 2 weeks (ExPr. 2); Three injections two weeks apart (low cumulative dose) and sacrifice either 2 weeks (ExPr. 3) or 12 weeks (ExPr. 4) after third injection; Five injections two weeks apart (high cumulative dose) and sacrifice 8 weeks after fifth injection (ExPr. 5). All groups were assessed by serial cardiac magnetic resonance (CMR) to quantify perfusion and invasive measurement of coronary flow reserve (CFR). At the end of each protocol, animals were sacrificed for ex vivo analyses. Vascular function was further evaluated by myography in explanted coronary arteries of pigs undergoing ExPr. 3 and controls.A single doxorubicin injection had no impact on microcirculation status, excluding a direct chemical toxicity. A series of five fortnightly doxorubicin injections (high cumulative dose) triggered a progressive decline in microcirculation status, evidenced by reduced CMR-based myocardial perfusion and CFR-measured impaired functional microcirculation. In the high cumulative dose regime (ExPr. 5), microcirculation changes appeared long before any contractile defect became apparent. Low cumulative doxorubicin dose (3 biweekly injections) was not associated with any contractile defect across long-term follow-up, but provoked persistent microcirculation damage, evident soon after third dose injection. Histological and myograph evaluations confirmed structural damage to arteries of all calibers even in animals undergoing low cumulative dose regimes. Conversely, arteriole damage and capillary bed alteration occurred only after high cumulative dose regime. Serial in vivo evaluations of microcirculation status using state-of-the-art CMR and invasive CFR show that anthracyclines treatment is associated with progressive and irreversible damage to the microcirculation. This long-persisting damage is present even in low cumulative dose regimes, which are not associated with cardiac contractile deficits. Microcirculation damage might explain some of the increased incidence of cardiovascular events in cancer survivors who received anthracyclines without showing cardiac contractile defects.
Repisalud
Publicación Artículo científico (JournalArticle)

Beta-3 adrenergic receptor overexpression reverses aortic stenosis-induced heart failure and restores balanced mitochondrial dynamics.

  • Pun-García, Andrés
  • Clemente-Moragón, Agustín
  • Villena-Gutierrez, Rocio
  • Gómez, Monica
  • Sanz-Rosa, David
  • Díaz-Guerra, Anabel
  • Prados, Belén
  • Medina, Juan Pablo
  • Montó, Fermí
  • Ivorra, Maria Dolores
  • Márquez-López, Cristina
  • Cannavo, Alessandro
  • Bernal, Juan A
  • Koch, Walter J
  • Fuster, Valentin
  • de la Pompa, Jose Luis
  • Oliver, Eduardo
  • Ibáñez, Borja
Aortic stenosis (AS) is associated with left ventricular (LV) hypertrophy and heart failure (HF). There is a lack of therapies able to prevent/revert AS-induced HF. Beta3 adrenergic receptor (β3AR) signaling is beneficial in several forms of HF. Here, we studied the potential beneficial effect of β3AR overexpression on AS-induced HF. Selective β3AR stimulation had a positive inotropic effect. Transgenic mice constitutively overexpressing human β3AR in the heart (c-hβ3tg) were protected from the development of HF in response to induced AS, and against cardiomyocyte mitochondrial dysfunction (fragmented mitochondria with remodeled cristae and metabolic reprogramming featuring altered substrate use). Similar beneficial effects were observed in wild-type mice inoculated with adeno-associated virus (AAV9) inducing cardiac-specific overexpression of human β3AR before AS induction. Moreover, AAV9-hβ3AR injection into wild-type mice at late disease stages, when cardiac hypertrophy and metabolic reprogramming are already advanced, reversed the HF phenotype and restored balanced mitochondrial dynamics, demonstrating the potential of gene-therapy-mediated β3AR overexpression in AS. Mice with cardiac specific ablation of Yme1l (cYKO), characterized by fragmented mitochondria, showed an increased mortality upon AS challenge. AAV9-hβ3AR injection in these mice before AS induction reverted the fragmented mitochondria phenotype and rescued them from death. In conclusion, our results step out that β3AR overexpression might have translational potential as a therapeutic strategy in AS-induced HF.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Simulating the Influence of Conjugative-Plasmid Kinetic Values on the Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model

  • Campos Frances, Marcelino
  • Sempere Luna, José María|||0000-0003-2393-9224
  • San Millan, Alvaro
  • Lanza, Val F.
  • Coque, Teresa M.
  • Llorens, Carlos
  • Baquero, Fernando
[EN] Bacterial plasmids harboring antibiotic resistance genes are critical in the spread of antibiotic resistance. It is known that plasmids differ in their kinetic values, i.e., conjugation rate, segregation rate by copy number incompatibility with related plasmids, and rate of stochastic loss during replication. They also differ in cost to the cell in terms of reducing fitness and in the frequency of compensatory mutations compensating plasmid cost. However, we do not know how variation in these values influences the success of a plasmid and its resistance genes in complex ecosystems, such as the microbiota. Genes are in plasmids, plasmids are in cells, and cells are in bacterial populations and microbiotas, which are inside hosts, and hosts are in human communities at the hospital or the community under various levels of cross-colonization and antibiotic exposure. Differences in plasmid kinetics might have consequences on the global spread of antibiotic resistance. New membrane computing methods help to predict these consequences. In our simulation, conjugation frequency of at least 10(-3) influences the dominance of a strain with a resistance plasmid. Coexistence of different antibiotic resistances occurs if host strains can maintain two copies of similar plasmids. Plasmid loss rates of 10(-4) or 10(-5) or plasmid fitness costs of >= 0.06 favor plasmids located in the most abundant species. The beneficial effect of compensatory mutations for plasmid fitness cost is proportional to this cost at high mutation frequencies (10(-3) to 10(-5)). The results of this computational model clearly show how changes in plasmid kinetics can modify the entire population ecology of antibiotic resistance in the hospital setting., F. Baquero, M. Campos, and T. M. Coque were supported by EU Joint Programming Initiative JPIAMR2016-AC16/00043 (JPIonAMR-Third call on Transmission, ST131TS project), the Health Institute Carlos III of Spain (grants PI15-00818 and PI18-01942 and CIBER [CIBER in Epidemiology and Public Health, CIBERESP; CB06/02/0053]), and the Regional Government of Madrid (InGEMICS-C; S2017/BMD-3691), all of them cofinanced by the European Development Regional Fund (ERDF) "A Way to Achieve Europe." A. San Millan was supported by the European Research Council under the European Union's Horizon 2020 Research and Innovation Program (ERC grant agreement number 757440-PLASREVOLUTION)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Simulating Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model

  • Campos Frances, Marcelino
  • Sempere Luna, José María|||0000-0003-2393-9224
  • Capilla, Rafael
  • Naya, Fernando
  • Futami, Ricardo
  • Coque, Teresa
  • Moya, Andrés
  • Fernández-Lanza, Val
  • Cantón, Rafael
  • Llorens, Carlos
  • Baquero, Fernando
[EN] Membrane computing is a bio-inspired computing paradigm whose devices are the so-called membrane systems or P systems. The P system designed in this work reproduces complex biological landscapes in the computer world. It uses nested "membrane-surrounded entities" able to divide, propagate, and die; to be transferred into other membranes; to exchange informative material according to flexible rules; and to mutate and be selected by external agents. This allows the exploration of hierarchical interactive dynamics resulting from the probabilistic interaction of genes (phenotypes), clones, species, hosts, environments, and antibiotic challenges. Our model facilitates analysis of several aspects of the rules that govern the multilevel evolutionary biology of antibiotic resistance. We examined a number of selected landscapes where we predict the effects of different rates of patient flow from hospital to the community and vice versa, the cross-transmission rates between patients with bacterial propagules of different sizes, the proportion of patients treated with antibiotics, and the antibiotics and dosing found in the opening spaces in the microbiota where resistant phenotypes multiply. We also evaluated the selective strengths of some drugs and the influence of the time 0 resistance composition of the species and bacterial clones in the evolution of resistance phenotypes. In summary, we provide case studies analyzing the hierarchical dynamics of antibiotic resistance using a novel computing model with reciprocity within and between levels of biological organization, a type of approach that may be expanded in the multilevel analysis of complex microbial landscapes., This work was supported by the European Commission, Seven Framework Program (EVOTAR; FP7-HEALTH-282004) to F. Baquero, T. Coque, V. Fernandez-Lanza, and M. Campos; the Instituto de Salud Carlos III of Spain (Plan Estatal de I+D+i 2013-2016, grant PI15-00818 and FIS18-1942; CIBERESP, grant CB06/02/0053, and the EU Joint Programming Initiative JPIAMR2016-AC16/00036 to F. Baquero; the Regional Government of Madrid (InGEMICS-C; S2017/BMD-3691) to T. Coque and F. Baquero; and SAF2015-65878-R (MINECO, Spain) and PrometeoII/2014/065 (Generalitat Valenciana, Spain) to A. Moya (all cofinanced by the European Development Regional Fund [ERDF] "A Way to Achieve Europe").
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Risk Predictors in a Spanish Cohort With Cardiac Laminopathies. The REDLAMINA Registry, Predictores de riesgo en una cohorte española con cardiolaminopatías. Registro REDLAMINA

  • Barriales-Villa, Roberto
  • Ochoa, Juan Pablo
  • Larrañaga Moreira, José María
  • Salazar-Mendiguchía, Joel
  • Díez-López, Carles
  • Restrepo-Córdoba, María Alejandra
  • Álvarez-Rubio, Jorge
  • Robles-Mezcua, Ainhoa
  • Olmo-Conesa, María C.
  • Nicolás-Rocamora, Elisa
  • Sanz, Jorge
  • Villacorta, Eduardo
  • Gallego-Delgado, María
  • Yotti, Raquel
  • Espinosa, María Ángeles
  • Manovel, Ana
  • Rincón-Díaz, Luis M.
  • Jiménez-Jáimez, Juan
  • Bermúdez-Jiménez, Francisco J.
  • Basurte-Elorz, M. Teresa
  • Climent-Payá, Vicente
  • García-Álvarez, María I.
  • Rodríguez-Palomares, José Fernando
  • Limeres-Freire, Javier
  • Pérez-Guerrero, Ainhoa
  • Cantero-Pérez, Eva M.
  • Peña-Peña, María Luisa
  • Palomino-Doza, Julián
  • Crespo-Leiro, María Generosa
  • García-Pinilla, José Manuel
  • Zorio, Esther
  • Ripoll-Vera, Tomás
  • García-Pavía, Pablo
  • Ortiz-Genga, Martín
  • Monserrat, Lorenzo
[Abstract] Introduction and objectives. According to sudden cardiac death guidelines, an implantable cardioverter-defibrillator (ICD) should be considered in patients with LMNA-related dilated cardiomyopathy (DCM) and ≥ 2 risk factors: male sex, left ventricular ejection fraction (LVEF) < 45%, nonsustained ventricular tachycardia (NSVT), and nonmissense genetic variants. In this study we aimed to describe the clinical characteristics of carriers of LMNA genetic variants among individuals from a Spanish cardiac-laminopathies cohort (REDLAMINA registry) and to assess previously reported risk criteria. Methods. The relationship between risk factors and cardiovascular events was evaluated in a cohort of 140 carriers (age ≥ 16 years) of pathogenic LMNA variants (54 probands, 86 relatives). We considered: a) major arrhythmic events (MAE) if there was appropriate ICD discharge or sudden cardiac death; b) heart failure death if there was heart transplant or death due to heart failure. Results. We identified 11 novel and 21 previously reported LMNA-related DCM variants. LVEF < 45% (P = .001) and NSVT (P < .001) were related to MAE, but not sex or type of genetic variant. The only factor independently related to heart failure death was LVEF < 45% (P < .001). Conclusions. In the REDLAMINA registry cohort, the only predictors independently associated with MAE were NSVT and LVEF < 45%. Therefore, female carriers of missense variants with either NSVT or LVEF < 45% should not be considered a low-risk group. It is important to individualize risk stratification in carriers of LMNA missense variants, because not all have the same prognosis., [Resumen] Introducción y objetivos. Según las guías de muerte súbita, se debe considerar un desfibrilador automático implantable (DAI) para los pacientes con miocardiopatía dilatada debida a variantes en el gen de la lamina (LMNA) con al menos 2 factores: varones, fracción de eyección del ventrículo izquierdo (FEVI) < 45%, taquicardia ventricular no sostenida (TVNS) y variantes no missense. Nuestro objetivo es describir las características clínicas de una cohorte española de pacientes con cardiolaminopatías (registro REDLAMINA) y evaluar los criterios de riesgo vigentes. Métodos. Se evaluó la relación entre factores de riesgo y eventos cardiovasculares en una cohorte de 140 portadores de variantes en LMNA (54 probandos, 86 familiares, edad ≥ 16 años). Se consideró: a) evento arrítmico mayor (EAM) si hubo descarga apropiada del DAI o muerte súbita, y b) muerte por insuficiencia cardiaca, incluidos los trasplantes. Resultados. Se identificaron 11 variantes nuevas y 21 previamente publicadas. La FEVI < 45% (p = 0,001) y la TVNS (p < 0,001) se relacionaron con los EAM, pero no el sexo o el tipo de variante (missense frente a no missense). La FEVI < 45% (p < 0,001) fue el único factor relacionado con la muerte por insuficiencia cardiaca. Conclusiones. En el registro REDLAMINA, los únicos 2 predictores asociados con EAM fueron la TVNS y la FEVI < 45%. No se debería considerar grupo de bajo riesgo a las portadoras de variantes missense con TVNS o FEVI < 45%. Es importante individualizar la estratificación del riesgo de los portadores de variantes missense en LMNA, porque no todas tienen el mismo pronóstico., This study received a grant from the Proyecto de investigación de la Sección de Insuficiencia Cardiaca 2017 from the Spanish Society of Cardiology and grants from the Instituto de Salud Carlos III (ISCIII) [PI14/0967, PI15/01551, AC16/0014] and ERA-CVD Joint Transnational Call 2016 (Genprovic). Grants from the ISCIII and the Ministerio de Economía y Competitividad de España (Spanish Department of Economy and Competitiveness) are supported by the Plan Estatal de I+D+i 2013-2016: Fondo Europeo de Desarrollo Regional (FEDER) “Una forma de hacer Europa”.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Protein Haploinsufficiency Drivers Identify MYBPC3 Variants That Cause Hypertrophic Cardiomyopathy

  • Suay-Corredera, Carmen
  • Pricolo, María Rosaria
  • Herrero-Galán, Elías
  • Velázquez-Carreras, Diana
  • Sánchez-Ortiz, David
  • García-Giustiniani, Diego
  • Delgado, Javier
  • Galano-Frutos, Juan José
  • García-Cebollada, Helena
  • Vilches, Silvia
  • Domínguez, Fernando
  • Sabater Molina, María
  • Barriales-Villa, Roberto
  • Frisso, Giulia
  • Sancho, Javier
  • Serrano, Luis
  • García-Pavía, Pablo
  • Monserrat, Lorenzo
  • Alegre-Cebollada, Jorge
[Abstract] Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. Variants in MYBPC3, the gene encoding cardiac myosin-binding protein C (cMyBP-C), are the leading cause of HCM. However, the pathogenicity status of hundreds of MYBPC3 variants found in patients remains unknown, as a consequence of our incomplete understanding of the pathomechanisms triggered by HCM-causing variants. Here, we examined 44 nontruncating MYBPC3 variants that we classified as HCM-linked or nonpathogenic according to cosegregation and population genetics criteria. We found that around half of the HCM-linked variants showed alterations in RNA splicing or protein stability, both of which can lead to cMyBP-C haploinsufficiency. These protein haploinsufficiency drivers associated with HCM pathogenicity with 100% and 94% specificity, respectively. Furthermore, we uncovered that 11% of nontruncating MYBPC3 variants currently classified as of uncertain significance in ClinVar induced one of these molecular phenotypes. Our strategy, which can be applied to other conditions induced by protein loss of function, supports the idea that cMyBP-C haploinsufficiency is a fundamental pathomechanism in HCM., J. A.-C. acknowledges funding from the Ministerio de Ciencia e Innovación (MCIN) through grants BIO2014-54768-P; BIO2017-83640-P/MINECO/AEI/FEDER, UE; EIN2019-102966 and RYC-2014-16604, the European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, Spain MINOTAUR, AC16/00045), and the Comunidad de Madrid (consortium Tec4Bio-CM, S2018/NMT-4443, FEDER). The CNIC is supported by the ISCIII, MCIN, and the Pro CNIC Foundation and was a Severo Ochoa Center of Excellence (SEV-2015-0505). We acknowledge funding from ISCIII to the Centro de Investigación Biomédica en Red (CB16/11/00425). L. S. acknowledges funding from MCIN (BFU2015-63571-P). J. S. acknowledges funding from AEI (PID2019-107293GB-I00), Gobierno de Aragón (E45_17R), and ERDF-InterregV-A POCTEFA, Spain (PIREPRED-EFA086/15). C. S.-C. is the recipient of an FPI-SO predoctoral fellowship BES-2016-076638. M. R. P. was the recipient of a PhD fellowship from the Italian Ministry of Education, Universities and Research, Italy. H. G.-C. is the recipient of an FPU16/04232 doctoral contract from MCIN, Comunidad de Madrid; S2018/NMT-4443, Gobierno de Aragón; E45_17R, Gobierno de Aragón; EFA086/15
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Overlapping prison/community tuberculosis outbreaks in Costa Rica revealed by alternative analysis of suboptimal material

  • Jbara, Sarah
  • Herranz, Marta
  • Sola-Campoy, Pedro J.
  • Rodríguez-Grande, Cristina
  • Chiner-Oms, Álvaro
  • Comas, Iñaki
  • Muñoz, Patricia
  • García de Viedma, Darío
  • Pérez-Lago, Laura
31 páginas, 5 figuras, 5 tablas, Costa Rica has a low incidence of tuberculosis. Thus, identifying transmission hotspots is key to implement interventions. A tuberculosis outbreak was suspected in a prison in Costa Rica. Given the suboptimal quality of the samples received in our laboratory in Madrid, we applied alternative schemes for their analysis. In the first scheme, we bypassed the standard approach of applying systematic mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) and used a strain-specific polymerase chain reaction (PCR) that allowed identifying a cluster involving six cases (C1). The second scheme followed the canonical MIRU-VNTR path coupled with a whole-genomic amplification step, by which a second unsuspected overlapping cluster (C2), was detected in the same prison. These findings justified the implementation of a surveillance programme adapted to local resources based on a tailored multiplex allele-specific oligonucleotide (ASO)-PCR targeting C1 and C2. Presence of the C2 strain at a different prison was determined. ASO-PCR was applied extensively and alerted to the active circulation of one of the strains within and beyond prisons. Our study shows that alternative methodological strategies may provide useful data in settings with lack of resources for performing systematic standard molecular epidemiology programmes and/or with suboptimal material for analysis., This work was supported by ERANet-LAC (AC16/00057; ELAC2015/T08-0664) and Instituto de Salud Carlos III (AC16/00057, FIS15/01554; 16/01449; 18/00599; 19/00331) and cofunded by European Regional Development Funds from the European Commission: ‘A way of making Europe'. LPL is holder of a Miguel Servet contract (CP15/00075), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expanded tracking of a Beijing Mycobacterium tuberculosis strain involved in an outbreak in France

  • Genestet, Charlotte
  • Perdigão, João
  • Herranz, Marta
  • Maus, Sandra R.
  • Pérez Lago, Laura
  • Berland, Jean-Luc
  • Chiner-Oms, Álvaro
  • Comas, Iñaki
  • Muñoz, Patricia
  • Portugal, Isabel
  • Dumitrescu, Oana
  • García de Viedma, Darío
14 páginas, 3 figuras, 1 tabla, Advanced epidemiological surveillance supported on genomic epidemiology were necessary to fully describe a Mycobacterium tuberculosis Beijing strain (ARA, Auvergne-Rhône-Alpes region) outbreak in France. The index case was a migrant from Cape Verde with a two-year history of tuberculosis, high bacillary load, and frequent trips within France and to Portugal. We designed an ARA-specific PCR to complete the tracking of this outbreak strain. The ARA-specific PCR was applied on 160 Beijing isolates from independent cases from the Auvergne-Rhône-Alpes region and on 25 cases from Cape Verde migrants in the Île-de-France region. No more cases were found, indicating that the previous surveillance had been exhaustive enough to capture the whole dimension of the outbreak in France. Next, we performed a cross-border surveillance, applying the PCR on 38 Beijing isolates in Portuthe gal. In all four cases (all migrants from Cape Verde) the ARA strain was identified. Whole genome sequences analysis of all ARA isolates representatives indicated a diversification of the strain into two variants present one in France and one in Portugal, This work was supported by ERANet-LAC [ELAC2015/T08-0664] and Instituto de Salud Carlos III [AC16/00057, FIS15/01554, FIS13/ 01207, CP15/00075, PI16/01449, 1PI19/00331] and cofounded by European Regional Development Funds from the European Commission: “A way of making Europe”. Miguel Servet Contract CP15/00075 and CPII20/00001) to LPL. JP [CEECIND/00394/2017] is supported by FCT through Estímulo Individual ao Emprego Cientifico., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Integrative transnational analysis to dissect tuberculosis transmission events along the migratory route from Africa to Europe

  • Martínez-Lirola, Miguel
  • Jajou, Rana
  • Mathys, Vanessa
  • Martin, Anandi
  • Maurizio Cabibbe, Andrea
  • Valera, Ana
  • Sola-Campoy, Pedro J.
  • Abascal, Estefanía
  • Rodríguez-Maus, Sandra
  • Garrido-Cárdenas, José Antonio
  • Bonillo, Magdalena
  • Chiner-Oms, Álvaro
  • López, Begoña
  • Vallejo-Godoy, Silvia
  • Comas, Iñaki
  • Muñoz, Patricia
  • Cirillo, Daniela Maria
  • Soolingen, Dick van
  • Pérez-Lago, Laura
  • García de Viedma, Darío
páginas, 4 figuras, 3 tablas, Background: Growing international migration has increased the complexity of tuberculosis transmission patterns. Italy's decision to close its borders in 2018 made of Spain the new European porte entrée for migration from the Horn of Africa (HA). In one of the first rescues of migrants from this region at the end of 2018, tuberculosis was diagnosed in eight subjects, mainly unaccompanied minors. Methods: Mycobacterium tuberculosis isolates from these recently arrived migrants were analysed by Mycobacterial Interspersed Repetitive-Unit/Variable-Number of Tandem Repeat (MIRU-VNTR) and subsequent whole genome sequencing (WGS) analysis. Data were compared with those from collections from other European countries receiving migrants from the HA and a strain-specific PCR was applied for a fast searching of common strains. Infections in a cellular model were performed to assess strain virulence. Results: MIRU-VNTR analysis allowed identifying an epidemiological cluster involving three of the eight cases from Somalia (0 single-nucleotide polymorphisms between isolates, HA cluster). Following detailed interviews revealed that two of these cases had shared the same migratory route in most of the trip and had spent a long time at a detention camp in Libya. To confirm potential en route transmission for the three cases, we searched the same strain in collections from other European countries receiving migrants from the HA. MIRU-VNTR, WGS and a strain-specific PCR for the HA strain were applied. The same strain was identified in 12 cases from Eritrea diagnosed soon after their arrival in 2018 to the Netherlands, Belgium and Italy. Intracellular replication rate of the strain did not reveal abnormal virulence. Conclusions: Our study suggests a potential en route transmission of a pan-susceptible strain, which caused at least 15 tuberculosis cases in Somalian and Eritrean migrants diagnosed in four different European countries., This work was supported by ERANet-LAC [ELAC2015/T08-0664] and Instituto de Salud Carlos III [AC16/00057, FIS15/01554, FIS13/01207, CP15/00075, PI19/00331] and cofounded by the European Regional Development Funds from the European Commission: ‘A way of making Europe’ and by Junta de Andalucia PI0488-2017., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Drivers of extended-spectrum β-lactamase (ESBL)- producing Enterobacterales colonization among residents of long-term care facilities: a European multicentre prospective cohort study

  • Göpel, Siri
  • Guther, Julia
  • Gladstone, Beryl Primrose
  • Conzelmann, Nadine
  • Bunk, Stefanie
  • Terzer, Tobias
  • Verschuuren, T. D.
  • Martak, Daniel
  • Salamanca, Elena
  • Autenrieth, I. B.
  • Peter, Silke
  • Kluytmans, Jan
  • Hocquet, Didier
  • Rodríguez-Baño, Jesús
  • Tacconelli, Evelina
The preliminary results of this study were presented online at the 30th European Congress of Clinical Microbiology and Infectious Diseases in Paris, France in April 2020 (Abstract # 6724)., MODERN WP1 Study Group (in addition to the authors listed above) Tübingen: Simone Eisenbeis, Florian Hölzl. Seville: Alvaro Pascual, Rocío Medina. Utrecht: Ad Fluit. All the authors stated above meet the required criteria of the International Committee of Medical Journal Editors., Background: Extended-spectrum β-lactamase (ESBL)-producing Enterobacterales (ESBL-PE) are highly prevalent in long-term care (LTCF) settings. In order to estimate the acquisition rate of ESBL-producing Escherichia coli and Klebsiella pneumoniae in LTCF settings, and identify clinical and environmental risk factors, a multi-centre, prospective cohort study was conducted in six LTCFs in Germany, France, Spain and the Netherlands., Methods: Longitudinal screening of residents was performed over 32 weeks, collecting epidemiological and clinical data and environmental samples. The primary outcome was the rate of new acquisition of ESBL-PE among LTCF residents. Molecular epidemiology was studied using whole genome sequencing, and risk factor analysis was undertaken using logistic and Poisson regression models., Results: In total, 299 residents provided 1958 samples during follow-up. The prevalence of ESBL-PE colonization at baseline was 16.4%, and the incidence of acquisition was 0.79 per 1000 resident-days, both with high variability between LTCFs. Age ≥80 years, vascular disease and antibiotic consumption within the preceding year were risk factors for baseline colonization. Lack of hand sanitizers and a low nurse:resident ratio were associated with colonization. The presence of medical devices was associated with risk of acquisition. Vascular disease, hemiplegia, antibiotic consumption, and non-availability of private bathrooms were associated with carriage of multiple sequence types (STs). The prevalence of ESBL-PE among environmental samples was 2%, exclusively in LTCFs with high prevalence among residents. Genetic analysis showed a high prevalence of ST10 E. coli and ST405 K. pneumoniae at two study sites., Conclusion: Infection prevention interventions, including availability of hand sanitizers, the number of nurses per resident, and antimicrobial stewardship, constitute important measures to control ESBL-PE in LTCFs. Genome-based surveillance could guide targeted interventions., This study was part of a Joint Programming Initiative on Antimicrobial Resistance collaborative research project, under the 2016 Joint Call Framework (Transnational Research Projects on the Transmission Dynamics of Antibacterial Resistance). It received funding from the following national research agencies: Spain: Instituto de Salud Carlos III (grant no. AC16/00076), Netherlands: Netherlands Organization for Health Research and Development (grant no. AC681055), France: Agence Nationale de la Recherche (grant no. ANR-16-JPEC-0007-03) and Germany: German Federal Ministry of Education and Research (grant no. 01KI1701). As part of a separate research project, ES, MD-V and JR-B received support for research from the Plan Nacional de I+D+i 2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), co- financed by the European Development Regional Fund ‘A way to achieve Europe’, Operative Program Intelligence Growth 2014-2020. BPG is funded by the German Centre for Infection Research Clinical Research Unit (DZIF-CRU) at Tübingen. The funders played no role in the study design, collection, analysis and interpretation of data, writing and submission for publication., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy

  • McGrail Fernández, Kimberley Anne
  • Granado Martinez, Paula
  • Esteve Puig, Rosaura
  • Garcia Ortega, Sara
  • Ding, Yuxin
  • Sanchez-Redondo Campos, Sara
  • Ferrer Fábrega, Berta
  • Hernandez Losa, Javier
  • Canals Suris, Francesc
  • Pérez, Mileidys
  • García-Patos Briones, Vicente
  • Recio Conde, Juan Angel
  • Muñoz Couselo, Eva
Glycolysis; Melanomas; Targeted therapy, Glucólisis; Melanomas; Terapia dirigida, Glucòlisi; Melanomes; Teràpia dirigida, NRAS-mutated melanoma lacks a specific line of treatment. Metabolic reprogramming is considered a novel target to control cancer; however, NRAS-oncogene contribution to this cancer hallmark is mostly unknown. Here, we show that NRASQ61-mutated melanomas specific metabolic settings mediate cell sensitivity to sorafenib upon metabolic stress. Mechanistically, these cells are dependent on glucose metabolism, in which glucose deprivation promotes a switch from CRAF to BRAF signaling. This scenario contributes to cell survival and sustains glucose metabolism through BRAF-mediated phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-2/3 (PFKFB2/PFKFB3). In turn, this favors the allosteric activation of phosphofructokinase-1 (PFK1), generating a feedback loop that couples glycolytic flux and the RAS signaling pathway. An in vivo treatment of NRASQ61 mutant melanomas, including patient-derived xenografts, with 2-deoxy-D-glucose (2-DG) and sorafenib effectively inhibits tumor growth. Thus, we provide evidence for NRAS-oncogene contributions to metabolic rewiring and a proof-of-principle for the treatment of NRASQ61-mutated melanoma combining metabolic stress (glycolysis inhibitors) and previously approved drugs, such as sorafenib., This work was funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, “A way to make Europe”/“Investing in your future”) PI14/0375-Fondos FEDER J.A.R., PI17/00043-Fondos FEDER; J.A.R., PI20/0384-Fondos FEDER; J.A.R., Euronanomed2-ISCIII (AC16/00019)-Fondos FEDER; J.A.R., Asociación Española Contra el Cancer (AECC-GCB15152978SOEN) (supported P.G.M., K.M.); J.A.R., Ramón Areces Foundation (supported K.M. and research); J.A.R. (PI17/00412)-Fondos FEDER; R.B., A.M., A.N.S. We thank A. Zorzano’s laboratory for technical assistance and performance of Seahorse technology.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation

  • Granado Martinez, Paula
  • García Ortega, Sara
  • González Sánchez, Elena
  • McGrail Fernández, Kimberley Anne
  • Selgas Sanchis, Rafael
  • Grueso Gragera, Judit
  • Gil Villaverde, Rosa
  • Naldaiz-Gastesi, Neia
  • Rhodes, Ana C
  • Hernandez Losa, Javier
  • Ferrer Fábrega, Berta
  • Canals Suris, Francesc
  • Villanueva Cardús, Josep
  • Mendez Fernández, Olga
  • García-Patos Briones, Vicente
  • Recio Conde, Juan Angel
  • Muñoz Couselo, Eva
Genètica del càncer; Càncer de pulmó; Oncògens, Genética del cáncer; Cáncer de pulmón; Oncogenes, Cancer genetics; Lung cancer; Oncogenes, Elucidating the contribution of somatic mutations to cancer is essential for personalized medicine. STK11 (LKB1) appears to be inactivated in human cancer. However, somatic missense mutations also occur, and the role/s of these alterations to this disease remain unknown. Here, we investigated the contribution of four missense LKB1 somatic mutations in tumor biology. Three out of the four mutants lost their tumor suppressor capabilities and showed deficient kinase activity. The remaining mutant retained the enzymatic activity of wild type LKB1, but induced increased cell motility. Mechanistically, LKB1 mutants resulted in differential gene expression of genes encoding vesicle trafficking regulating molecules, adhesion molecules and cytokines. The differentially regulated genes correlated with protein networks identified through comparative secretome analysis. Notably, three mutant isoforms promoted tumor growth, and one induced inflammation-like features together with dysregulated levels of cytokines. These findings uncover oncogenic roles of LKB1 somatic mutations, and will aid in further understanding their contributions to cancer development and progression., This work was supported by funds from the Spanish Health Ministry (Fondo de Investigaciones Sanitarias-FIS) PI1400375-Fondos FEDER, PI17/00043-Fondos FEDER, Euronanomed2-ISCIII (AC16/00019)-Fondos FEDER, Asociación Española Contra el Cancer (AECC-GCB15152978SOEN) supported PGM, KM., Ramón Areces Foundation supported KM and research.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cervical Electrical Neuromodulation Effectively Enhances Hand Motor Output in Healthy Subjects by Engaging a Use-Dependent Intervention

  • Kumru, Hatice|||0000-0002-0501-1660
  • Flores de los Heros, Africa|||0000-0003-0720-2409
  • Rodríguez-Cañón, María|||0000-0003-4093-5292
  • Edgerton, Victor|||0000-0001-6534-1875
  • García-Alén, Loreto|||0000-0001-9910-9476
  • Benito-Penalva, Jesús|||0000-0003-1232-1808
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Gerasimenko, Yury P.|||0000-0002-9345-3791
  • García Alias, Guillermo|||0000-0003-0197-0503
  • Vidal, Joan|||0000-0002-3952-2442
Electrical enabling motor control (eEmc) through transcutaneous spinal cord stimulation is a non-invasive method that can modify the functional state of the sensory-motor system. We hypothesize that eEmc delivery, together with hand training, improves hand function in healthy subjects more than either intervention alone by inducing plastic changes at spinal and cortical levels. Ten voluntary participants were included in the following three interventions: (i) hand grip training, (ii) eEmc, and (iii) eEmc with hand training. Functional evaluation included the box and blocks test (BBT) and hand grip maximum voluntary contraction (MVC), spinal and cortical motor evoked potential (sMEP and cMEP), and resting motor thresholds (RMT), short interval intracortical inhibition (SICI), and F wave in the abductor pollicis brevis muscle. eEmc combined with hand training retained MVC and increased F wave amplitude and persistency, reduced cortical RMT and facilitated cMEP amplitude. In contrast, eEmc alone only increased F wave amplitude, whereas hand training alone reduced MVC and increased cortical RMT and SICI. In conclusion, eEmc combined with hand grip training enhanced hand motor output and induced plastic changes at spinal and cortical level in healthy subjects when compared to either intervention alone. These data suggest that electrical neuromodulation changes spinal and, perhaps, supraspinal networks to a more malleable state, while a concomitant use-dependent mechanism drives these networks to a higher functional state.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation

  • Granado-Martínez, Paula|||0000-0002-7765-8914
  • Garcia-Ortega, Sara|||0000-0002-4404-5441
  • González-Sánchez, Elena
  • McGrail, Kimberley|||0000-0001-7227-7306
  • Selgas, Rafael|||0000-0002-5060-3841
  • Grueso, Judit|||0000-0003-1093-7940
  • Gil Villaverde, Rosa
  • Naldaiz-Gastesi, Neia
  • Rhodes, Ana C.
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Ferrer, Berta|||0000-0002-1255-4647
  • Canals, Francesc|||0000-0002-0650-1135
  • Villanueva, Josep|||0000-0003-1396-9470
  • Méndez Fernández, Olga|||0000-0003-4237-330X
  • Espinosa-Gil, Sergio|||0000-0002-2873-8475
  • Lizcano de Vega, José Miguel|||0000-0002-3154-5383
  • Muñoz Couselo, Eva|||0000-0001-7556-7608
  • García-Patos Briones, Vicente|||0000-0003-1654-6035
  • Recio Conde, Juan Ángel|||0000-0002-7320-3832
Elucidating the contribution of somatic mutations to cancer is essential for personalized medicine. STK11 (LKB1) appears to be inactivated in human cancer. However, somatic missense mutations also occur, and the role/s of these alterations to this disease remain unknown. Here, we investigated the contribution of four missense LKB1 somatic mutations in tumor biology. Three out of the four mutants lost their tumor suppressor capabilities and showed deficient kinase activity. The remaining mutant retained the enzymatic activity of wild type LKB1, but induced increased cell motility. Mechanistically, LKB1 mutants resulted in differential gene expression of genes encoding vesicle trafficking regulating molecules, adhesion molecules and cytokines. The differentially regulated genes correlated with protein networks identified through comparative secretome analysis. Notably, three mutant isoforms promoted tumor growth, and one induced inflammation-like features together with dysregulated levels of cytokines. These findings uncover oncogenic roles of LKB1 somatic mutations, and will aid in further understanding their contributions to cancer development and progression. Paula Granado-Martínez, Sara Ortega, Elena González-Sánchez et al. report a functional analysis of four cancer-associated mutant isoforms of the gene STK11 using cell-based and animal models. They find the mutant isoforms no longer show tumor suppressor activity, promote tumor growth, and affect the regulation of cytokines and genes involved in vesicle trafficking.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transcutaneous electrical neuromodulation of the cervical spinal cord depends both on the stimulation intensity and the degree of voluntary activity for training. A pilot study

  • Kumru, Hatice|||0000-0002-0501-1660
  • Rodríguez-Cañón, María|||0000-0003-4093-5292
  • Edgerton, Victor|||0000-0001-6534-1875
  • García-Alén, Loreto|||0000-0001-9910-9476
  • Flores de los Heros, Africa|||0000-0003-0720-2409
  • Soriano Crespo, Ignasi
  • Opisso, Eloy|||0000-0002-6868-6737
  • Gerasimenko, Yury P.|||0000-0002-9345-3791
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • García Alias, Guillermo|||0000-0003-0197-0503
  • Vidal, Joan|||0000-0002-3952-2442
Electrical enabling motor control (eEmc) through transcutaneous spinal cord stimulation offers promise in improving hand function. However, it is still unknown which stimulus intensity or which muscle force level could be better for this improvement. Nine healthy individuals received the following interventions: (i) eEmc intensities at 80%, 90% and 110% of abductor pollicis brevis motor threshold combined with hand training consisting in 100% handgrip strength; (ii) hand training consisting in 100% and 50% of maximal handgrip strength combined with 90% eEmc intensity. The evaluations included box and blocks test (BBT), maximal voluntary contraction (MVC), F wave persistency, F/M ratio, spinal and cortical motor evoked potentials (MEP), recruitment curves of spinal MEP and cortical MEP and short-interval intracortical inhibition. The results showed that: (i) 90% eEmc intensity increased BBT, MVC, F wave persistency, F/M ratio and cortical MEP recruitment curve; 110% eEmc intensity increased BBT, F wave persistency and cortical MEP and recruitment curve of cortical MEP; (ii) 100% handgrip strength training significantly modulated MVC, F wave persistency, F/M wave and cortical MEP recruitment curve in comparison to 50% handgrip strength. In conclusion, eEmc intensity and muscle strength during training both influence the results for neuromodulation at the cervical level.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transcutaneous Cervical Spinal Cord Stimulation Combined with Robotic Exoskeleton Rehabilitation for the Upper Limbs in Subjects with Cervical SCI, Clinical Trial

  • García-Alén, Loreto|||0000-0001-9910-9476
  • Kumru, Hatice|||0000-0002-0501-1660
  • Castillo-Escario, Yolanda|||0000-0002-7493-1268
  • Benito-Penalva, Jesús|||0000-0003-1232-1808
  • Medina-Casanovas, Josep
  • Gerasimenko, Yury P.|||0000-0002-9345-3791
  • Edgerton, Victor|||0000-0001-6534-1875
  • García Alias, Guillermo|||0000-0003-0197-0503
  • Vidal, Joan|||0000-0002-3952-2442
Restoring arm and hand function is a priority for individuals with cervical spinal cord injury (cSCI) for independence and quality of life. Transcutaneous spinal cord stimulation (tSCS) promotes the upper extremity (UE) motor function when applied at the cervical region. The aim of the study was to determine the effects of cervical tSCS, combined with an exoskeleton, on motor strength and functionality of UE in subjects with cSCI. Twenty-two subjects participated in the randomized mix of parallel-group and crossover clinical trial, consisting of an intervention group (n = 15; tSCS exoskeleton) and a control group (n = 14; exoskeleton). The assessment was carried out at baseline, after the last session, and two weeks after the last session. We assessed graded redefined assessment of strength, sensibility, and prehension (GRASSP), box and block test (BBT), spinal cord independence measure III (SCIM-III), maximal voluntary contraction (MVC), ASIA impairment scale (AIS), and WhoQol-Bref; GRASSP, BBT, SCIM III, cylindrical grip force and AIS motor score showed significant improvement in both groups (p ≤ 0.05), however, it was significantly higher in the intervention group than the control group for GRASSP strength, and GRASSP prehension ability (p ≤ 0.05); Our findings show potential advantages of the combination of cervical tSCS with an exoskeleton to optimize the outcome for UE.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Detection of Sleep-Disordered Breathing in Patients with Spinal Cord Injury Using a Smartphone

  • Castillo-Escario, Yolanda|||0000-0002-7493-1268
  • Kumru, Hatice|||0000-0002-0501-1660
  • Ferrer-Lluis, Ignasi|||0000-0002-0281-9023
  • Vidal, Joan|||0000-0002-3952-2442
  • Jané Campos, Raimon|||0000-0002-6541-8729
Patients with spinal cord injury (SCI) have an increased risk of sleep-disordered breathing (SDB), which can lead to serious comorbidities and impact patients' recovery and quality of life. However, sleep tests are rarely performed on SCI patients, given their multiple health needs and the cost and complexity of diagnostic equipment. The objective of this study was to use a novel smartphone system as a simple non-invasive tool to monitor SDB in SCI patients. We recorded pulse oximetry, acoustic, and accelerometer data using a smartphone during overnight tests in 19 SCI patients and 19 able-bodied controls. Then, we analyzed these signals with automatic algorithms to detect desaturation, apnea, and hypopnea events and monitor sleep position. The apnea-hypopnea index (AHI) was significantly higher in SCI patients than controls (25 ± 15 vs. 9 ± 7, p < 0.001). We found that 63% of SCI patients had moderate-to-severe SDB (AHI ≥ 15) in contrast to 21% of control subjects. Most SCI patients slept predominantly in supine position, but an increased occurrence of events in supine position was only observed for eight patients. This study highlights the problem of SDB in SCI and provides simple cost-effective sleep monitoring tools to facilitate the detection, understanding, and management of SDB in SCI patients.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy

  • McGrail Fernández, Kimberley Anne
  • Granado Martinez, Paula
  • Esteve Puig, Rosaura
  • Garcia Ortega, Sara
  • Ding, Yuxin
  • Sanchez-Redondo Campos, Sara
  • Ferrer Fábrega, Berta
  • Hernandez Losa, Javier
  • Canals Suris, Francesc
  • Pérez, Mileidys
  • García-Patos Briones, Vicente
  • Recio Conde, Juan Angel
  • Muñoz Couselo, Eva
Glycolysis; Melanomas; Targeted therapy, Glucólisis; Melanomas; Terapia dirigida, Glucòlisi; Melanomes; Teràpia dirigida, NRAS-mutated melanoma lacks a specific line of treatment. Metabolic reprogramming is considered a novel target to control cancer; however, NRAS-oncogene contribution to this cancer hallmark is mostly unknown. Here, we show that NRASQ61-mutated melanomas specific metabolic settings mediate cell sensitivity to sorafenib upon metabolic stress. Mechanistically, these cells are dependent on glucose metabolism, in which glucose deprivation promotes a switch from CRAF to BRAF signaling. This scenario contributes to cell survival and sustains glucose metabolism through BRAF-mediated phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-2/3 (PFKFB2/PFKFB3). In turn, this favors the allosteric activation of phosphofructokinase-1 (PFK1), generating a feedback loop that couples glycolytic flux and the RAS signaling pathway. An in vivo treatment of NRASQ61 mutant melanomas, including patient-derived xenografts, with 2-deoxy-D-glucose (2-DG) and sorafenib effectively inhibits tumor growth. Thus, we provide evidence for NRAS-oncogene contributions to metabolic rewiring and a proof-of-principle for the treatment of NRASQ61-mutated melanoma combining metabolic stress (glycolysis inhibitors) and previously approved drugs, such as sorafenib., This work was funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, “A way to make Europe”/“Investing in your future”) PI14/0375-Fondos FEDER J.A.R., PI17/00043-Fondos FEDER; J.A.R., PI20/0384-Fondos FEDER; J.A.R., Euronanomed2-ISCIII (AC16/00019)-Fondos FEDER; J.A.R., Asociación Española Contra el Cancer (AECC-GCB15152978SOEN) (supported P.G.M., K.M.); J.A.R., Ramón Areces Foundation (supported K.M. and research); J.A.R. (PI17/00412)-Fondos FEDER; R.B., A.M., A.N.S. We thank A. Zorzano’s laboratory for technical assistance and performance of Seahorse technology.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation

  • Granado Martinez, Paula
  • García Ortega, Sara
  • González Sánchez, Elena
  • McGrail Fernández, Kimberley Anne
  • Selgas Sanchis, Rafael
  • Grueso Gragera, Judit
  • Gil Villaverde, Rosa
  • Naldaiz-Gastesi, Neia
  • Rhodes, Ana C
  • Hernandez Losa, Javier
  • Ferrer Fábrega, Berta
  • Canals Suris, Francesc
  • Villanueva Cardús, Josep
  • Mendez Fernández, Olga
  • García-Patos Briones, Vicente
  • Recio Conde, Juan Angel
  • Muñoz Couselo, Eva
Genètica del càncer; Càncer de pulmó; Oncògens, Genética del cáncer; Cáncer de pulmón; Oncogenes, Cancer genetics; Lung cancer; Oncogenes, Elucidating the contribution of somatic mutations to cancer is essential for personalized medicine. STK11 (LKB1) appears to be inactivated in human cancer. However, somatic missense mutations also occur, and the role/s of these alterations to this disease remain unknown. Here, we investigated the contribution of four missense LKB1 somatic mutations in tumor biology. Three out of the four mutants lost their tumor suppressor capabilities and showed deficient kinase activity. The remaining mutant retained the enzymatic activity of wild type LKB1, but induced increased cell motility. Mechanistically, LKB1 mutants resulted in differential gene expression of genes encoding vesicle trafficking regulating molecules, adhesion molecules and cytokines. The differentially regulated genes correlated with protein networks identified through comparative secretome analysis. Notably, three mutant isoforms promoted tumor growth, and one induced inflammation-like features together with dysregulated levels of cytokines. These findings uncover oncogenic roles of LKB1 somatic mutations, and will aid in further understanding their contributions to cancer development and progression., This work was supported by funds from the Spanish Health Ministry (Fondo de Investigaciones Sanitarias-FIS) PI1400375-Fondos FEDER, PI17/00043-Fondos FEDER, Euronanomed2-ISCIII (AC16/00019)-Fondos FEDER, Asociación Española Contra el Cancer (AECC-GCB15152978SOEN) supported PGM, KM., Ramón Areces Foundation supported KM and research.